Product specification
Product: Specification no.: Shelf life/retest period:
EPAX 4030 TGN 100021-20 1095 days
This edition approved: Previous edition approved: First edition approved:
04.05.2022 09.03.2022 03.07.2014
Approved by [electronically signed]:
Trine Fiskaa Hagen Lie
Test Min. value Max. value Unit Method
Appearance at room temperature: Clear oil 611059
Acid Value 0.7 mg KOH/g 611002
Colour 6 Gardner 611065
Peroxide value 1.2 meq/kg 611009
Anisidine value 8 - 611014
Total oxidation 10 - 611136
Absorbance 233 nm 0.50 AU 611047
EPA; Eicosapentaenoic acid C20:5 (TG) 400 mg/g 611129
DHA; Docosahexaenoic acid C22:6 (TG) 300 mg/g 611129
DPA; Docosapentaenoic acid C22:5 (TG) mg/g 611129
Total omega-3 (7 TG): EPA, DHA, DPA, 18:3, 18:4, 20:4, 21:5 780 mg/g 611129
EPA: Eicosapentaenoic acid C20:5 (TG) A% 611129
DHA; Docosahexaenoic acid C22:6 (TG) A% 611129
DPA; Docosapentaenoic acid C22:5 n-3 (TG) A% 611129
Total omega-3 (7 TG): EPA, DHA, DPA, 18:3, 18:4, 20:4, 21:5 A% 611129
Triglycerides 90 A% 611064
Diglycerides A% 611064
Monoglycerides A% 611064
Oligomers 0.5 A% 611064
Ethyl esters and free fatty acids 3 A% 611064
Mixed tocopherol 3.0 4.5 mg/g 611081
Epax Norway AS Telephone: +47 70 13 59 60 SWIFT/BIC: DNBANOKKXXX
P.O. Box 2047, 6028 Ålesund E-mail: epax@pelagia.com Bank account: 15039928652
Aarsæthervegen 17, 6006 Ålesund Web: www.epax.com IBAN NOK: NO3015039928652
Norway Org./VAT No.: 989100106MVA Foretaksregisteret
Page 1 of 2
Product specification
Product: Specification no.: Shelf life/retest period:
EPAX 4030 TGN 100021-20 1095 days
This edition approved: Previous edition approved: First edition approved:
04.05.2022 09.03.2022 03.07.2014
Approved by [electronically signed]:
Trine Fiskaa Hagen Lie
Test Min. value Max. value Unit Method
Frequency testing once per year: ddmmyy -
Unsaponifiable matter 3.0 % 611096
Frequency testing three times per year: ddmmyy -
As, Arsenic 0.05 mg/kg 611500
Cd, Cadmium 0.002 mg/kg 611500
Pb, Lead 0.01 mg/kg 611500
Hg, Mercury 0.005 mg/kg 611500
DDT (sum: o,p' + p,p') 0.005 mg/kg 611500
DDD (sum: o,p' + p,p') 0.005 mg/kg 611500
DDE p,p' 0.005 mg/kg 611500
HCB 0.005 mg/kg 611500
PCBs all 209 0.005 mg/kg 611521
Brominated flame retardants 0.002 mg/kg 611500
IUPAC no. 47, 99, 100, 153, 154, 183
DEHP 1 mg/kg 611525
Benzo(a)pyrene 0.5 ng/g 611500
Sum 4 PAH 2.0 ng/g 611500
Dioxinlike PCBs (TE WHO) 0.5 pg/g 611516
Dioxins+furans (TE WHO) 0.5 pg/g 611516
Dioxins+furans+dioxinlike PCBs (TE WHO) 1 pg/g 611516
Trans fatty acids (sum of 10) 0.5 % 611509
Total 3-MCPD (free and bound) 0.5 mg/kg 611529
Ester-bound 3-chloropropane-1,2-diol (3-MCPD ester)
Glycidol (calc.) 0.5 mg/kg 611529
Calc. 3-MCPD forming substances (glycidol) on fat
Shelf life is guaranteed if product is stored in unopened original closed containers, protected from heat and light.
EPAX products do not contain any components of GMO origin, IP certified tocopherols are added.
Epax Norway AS Telephone: +47 70 13 59 60 SWIFT/BIC: DNBANOKKXXX
P.O. Box 2047, 6028 Ålesund E-mail: epax@pelagia.com Bank account: 15039928652
Aarsæthervegen 17, 6006 Ålesund Web: www.epax.com IBAN NOK: NO3015039928652
Norway Org./VAT No.: 989100106MVA Foretaksregisteret
Page 2 of 2
TECHNICAL DATA SHEET
SOFTGEL SEAMEGA EPAX 4030 TG-XO® Ultra - 1 g
Fish gelatin
Code: CAA-EP4030TGN.XO
Packaged in box of 6 000 capsules
Specification
Raw material: Seamega oil TG-XO® Ultra (from Epax®, highly deodorized)
Product category: food supplement
Ingredients to be declared
Fish oil, fish gelatin, humectant: glycerol (E422), antioxidants: rosemary extracts (E392) and mixed
tocopherol (E306)
Lubricant (processing aid) not to be declared
Encapsulation lubricant: sunflower lecithin, MCT or carnauba wax.
Composition
Empty capsule average weight 357 mg +/- 31%
Oil weight per capsule 1000 mg +/- 7.5%
Average total weight 1357 mg +/- 12%
Nutritional values
Per capsule For 100 g
Oil approx. 1000 mg Oil approx. 72.3 g
Fatty acids profile in mg as FA in mg as TG in g as FA in g as TG
Total omega fatty acids* 750 780 55.2 57.4
Eicosapentaenoic acid C20:5 n-3* 384 400 28.3 29.4
Docosahexaenoic acid C22:6 n-3* 288 300 21.2 22.1
* The above mentioned values of EPA, DHA and Total omega fatty acids are the minimal values guaranteed for 1000 mg of Seamega
oil from Epax®
Recommendations and use precaution
- Take capsule(s) with a glass of water, during lunch
- Keep it away from children
- Cannot replace a varied and well-balanced diet and a healthy lifestyle
- Allergen statement under request
- Polyols: «excessive consumption may induce laxative effects»
7-11 chemin de Kilourin, 29170 Pleuven - France │ +33(0) 298 504 160 │ contact@seanova.fr│ www.seanova.fr 1/2
TECHNICAL DATA SHEET
Health claims authorized in Europe
According to « COMMISSION REGULATION (EU) No 432/2012 of 16 May 2012 and No 440/2011 of 6
may 2011» the following claims are authorized. Claims conditions are specified under each of them.
• Docosahexaenoic acid (DHA) contributes to maintenance of normal brain function
The claim may be used only for food which contains at least 40 mg of DHA per 100 g and per 100 kcal.
In order to bear the claim information shall be given to the consumer that the beneficial effect is obtained
with a daily intake of 250 mg of DHA.
• Docosahexaenoic acid (DHA) contributes to the maintenance of normal vision
The claim may be used only for food which contains at least 40 mg of DHA per 100 g and per 100 kcal.
In order to bear the claim information shall be given to the consumer that the beneficial effect is obtained
with a daily intake of 250 mg of DHA.
• Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) contribute to the normal function
of the heart
The claim may be used only for food which is at least a source of EPA and DHA as referred to in the claim
source of omega-3 fatty acids as listed in the Annex to Regulation (EC) No 1924/2006. In order to bear
the claim information shall be given to the consumer that the beneficial effect is obtained with a daily
intake of 250 mg of EPA and DHA.
• Docosahexaenoic acid (DHA) maternal intake contributes to the normal brain development of
the fœtus and breastfed infants
Information shall be given to pregnant and lactating women that the beneficial effect is obtained with a
daily intake of 200mg of DHA in addition to the recommended daily intake for omega-3 fatty acids for
adult, i.e. 250 mg DHA and EPA.
The claim can be used only for food which provides a daily intake of at least 200 mg DHA.
This edition approved on the: June 09, 2023
Prepared by: Fabien Grondeau Verified by: Guy Nguema Allogho
7-11 chemin de Kilourin, 29170 Pleuven - France │ +33(0) 298 504 160 │ contact@seanova.fr│ www.seanova.fr 2/2
